Brain disorders associated with corticotropin-releasing hormone expression in the placenta among children born before the 28th week of gestation

Acta Paediatrica, International Journal of Paediatrics

Volumn 105, Issue 1, 2016, Pages e7-e11

  Leviton, Alan ^a   Allred, Elizabeth N ^a   Kuban, Karl C K ^b   O'Shea, Thomas Michael ^c   Paneth, Nigel ^d   Majzoub, Joseph ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Brain; Corticosteroid; Corticotropin releasing hormone; Development; Infant; Placenta; Premature

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; BIOLOGICAL MARKER;

ARTICLE; BAYLEY MOTOR SCALE; BAYLEY SCALES OF INFANT DEVELOPMENT; BRAIN DISEASE; BRAIN VENTRICLE DILATATION; CEREBRAL PALSY; DISEASE ASSOCIATION; ECHOGRAPHY; EXTREMELY PRETERM INFANT; GENE EXPRESSION; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; MAJOR CLINICAL STUDY; MOTOR DYSFUNCTION ASSESSMENT; NEWBORN; NEWBORN INTENSIVE CARE; PLACENTA; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; QUADRIPARETIC CEREBRAL PALSY; BRAIN DAMAGE, CHRONIC; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HYDROCEPHALUS; INFANT, PREMATURE, DISEASES; METABOLISM; MOTOR DISORDERS; PREGNANCY; PRENATAL EXPOSURE; PRESCHOOL CHILD; STATISTICAL MODEL;

BIOMARKERS; BRAIN DAMAGE, CHRONIC; CHILD, PRESCHOOL; CORTICOTROPIN-RELEASING HORMONE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCEPHALUS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; LOGISTIC MODELS; MOTOR DISORDERS; PLACENTA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; ULTRASONOGRAPHY;

EID: 84952837628     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.13174     Document Type: Article

References (17)

1. Malaeb SN, Stonestreet BS,. Steroids and Injury to the Developing Brain. Clin Perinatol 2014; 41: 191-208.
2. LeWinn KZ, Stroud LR, Molnar BE, Ware JH, Koenen KC, Buka SL,. Elevated maternal cortisol levels during pregnancy are associated with reduced childhood IQ. Int J Epidemiol 2009; 38: 1700-10.
3. Sandman CA, Davis EP, Buss C, Glynn LM,. Prenatal programming of human neurological function. Int J Pept 2011; 2011: 837596.
4. Aucott SW, Watterberg KL, Shaffer ML, Donohue PK,. Do cortisol concentrations predict short-term outcomes in extremely low birth weight infants? Pediatrics 2008; 122: 775-81.
5. Power ML, Schulkin J,. Functions of corticotropin-releasing hormone in anthropoid primates: from brain to placenta. Am J Hum Biol 2006; 18: 431-4.
6. Magiakou MA, Mastorakos G, Webster E, Chrousos GP,. The hypothalamic-pituitary-adrenal axis and the female reproductive system. Ann N Y Acad Sci 1997; 816: 42-56.
7. Trivedi S, Joachim M, McElrath T, Kliman H, Allred EN, Fichorova RN, et al., Fetal inflammation, not adrenal activation, in extreme preterm delivery. Am J Obstet Gynecol 2012; 206: 236. e1-8.
8. O'Shea TM, Washburn LK, Nixon PA, Goldstein DJ,. Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age. Pediatrics 2007; 120: 594-602.
9. Rademaker KJ, de Vries WB,. Long-term effects of neonatal hydrocortisone treatment for chronic lung disease on the developing brain and heart. Semin Fetal Neonatal Med 2009; 14: 171-7.
10. Benediktsson R, Calder AA, Edwards CR, Seckl JR,. Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol (Oxf). 1997; 46: 161-6.
11. Leviton A, Allred EN, Kuban KC, Hecht JL, Onderdonk AB, O'Shea TM, et al., Microbiologic and histologic characteristics of the extremely preterm infant's placenta predict white matter damage and later cerebral palsy. The ELGAN study. Pediatr Res 2010; 67: 95-101.
12. Leviton A, Kuban K, O'Shea TM, Paneth N, Fichorova R, Allred EN, et al., The Relationship between early concentrations of 25 blood proteins and cerebral white matter injury in preterm newborns: The ELGAN Study. J Pediatr 2011; 158: 897-903.e5.
13. Kuban KC, O'Shea TM, Allred EN, Paneth N, Hirtz D, Fichorova RN, et al., Systemic inflammation and cerebral palsy risk in extremely preterm infants. J Child Neurol 2014; 29: 1692-98.
14. Stallones RA,. The use and abuse of subgroup analysis in epidemiological research. Prev Med 1987; 16: 183-94.
15. Tegethoff M, Pryce C, Meinlschmidt G,. Effects of intrauterine exposure to synthetic glucocorticoids on fetal, newborn, and infant hypothalamic-pituitary-adrenal axis function in humans: a systematic review. Endocr Rev 2009; 30: 753-89.
16. Amath A, Foster JA, Sidor MM,. Developmental alterations in CNS stress-related gene expression following postnatal immune activation. Neuroscience 2012; 220: 90-9.
17. Kuypers E, Ophelders D, Jellema RK, Kunzmann S, Gavilanes AW, Kramer BW,. White matter injury following fetal inflammatory response syndrome induced by chorioamnionitis and fetal sepsis: lessons from experimental ovine models. Early Hum Dev 2012; 88: 931-6.